WhatsApp Skip to main content

Dr. Harsh J Shah

Surgery or Imatinib First for GIST? How the Order Is Set

Last updated: 17-Nov-2026

Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Dr Harsh Shah, stomach cancer surgeon, Ahmedabad

Dr Harsh Shah
MS, MCh (Surgical Gastroenterology), DrNB (Surgical Gastroenterology)
Registered with Gujarat Medical Council, Reg. No. G-38738
Stomach Cancer Surgeon
Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad · 18 years of experience

In short

GIST care mixes an operation with a targeted tablet, imatinib. A tumour that can be removed safely is operated on first. A large or awkward one often gets tablets first.

After full removal, tablets are for higher-risk tumours, usually for three years. If the GIST has spread, tablets come first and carry on while they work.

One team plans the whole path before the first step, so that an early choice does not shut off a later one.

For the whole story of GIST, from the first test to imatinib and surgery, read our GIST treatment in Ahmedabad page. This post explains how the operation and the tablets are put in order.

What decides the order of GIST treatment?

Three things decide it: how far the tumour has reached, which gene change drives it, and how likely it is to return. Your team checks all three first.

  • Reach means the size and the organ it sits in. It also means whether the tumour presses on nearby structures or has spread to the liver or belly lining.
  • The gene change decides which tablet and which dose will work. It also tells us who will gain nothing from imatinib.
  • The chance of return is judged after the tumour is removed and looked at under the microscope. It sets whether tablets are needed afterwards.

This is why a gene report and a good scan are asked for before any decision. Our post on how a GIST is confirmed with CT, scope and biopsy explains what is sent and when.

Which comes first in each situation?

The first step follows the situation. Removal comes first when it is safe and complete. Tablets come first when removal is risky, or when the disease has spread.

The usual first step for each GIST situation, and what follows
SituationUsual first stepWhat follows
Tumour can be removed fully and safelyOperationTablets for three years if the risk is high and the gene type responds
Large, or touching other organs, or removal would take much more than the tumourImatinib for several monthsScans, then the operation at the right moment, then tablets again
Tumour in the low rectum, the food-pipe junction or the duodenumImatinib, so that a smaller operation may doA limited removal where possible, then tablets by risk
Spread to the liver or belly lining at diagnosisImatinib, started after the biopsy and gene reportTablets continue; an operation only for chosen patients
PDGFRA D842V gene changeOperation if removable; imatinib is not usedA different tablet, avapritinib, if the disease needs medicine

Please read the table as a guide, not a rule. Two tumours of the same size can need different orders because their gene change or position differs.

When is the operation done first?

When the whole tumour can be taken out in one piece, surgery comes first. A tumour that bursts during the operation is more likely to return, so it is handled with care.

  • Many gastric GISTs can be removed with a wedge. The lump comes out with a clear rim and most of the stomach stays.
  • Lymph glands are not usually removed, because GIST seldom travels through them.
  • Where the position allows it, laparoscopic surgery is used. A very large or fragile tumour is better removed by open surgery.

The tumour is then studied under the microscope for size, the number of dividing cells and the site. These set the risk group, which settles the tablets. Our post on how common GIST is and what types exist explains how these groups are formed.

Why are tablets given before the operation?

Imatinib can shrink a large tumour so that it comes out cleanly with a smaller operation. It is used when operating first would be risky or incomplete.

  • A tumour near the food-pipe junction may need the whole stomach removed if operated at once. After shrinkage, a partial removal may do.
  • A low rectal tumour may need the anal sphincter taken out. Shrinkage can let it be saved.
  • A tumour that has grown into a neighbouring organ may be separated safely only after it has shrunk and hardened.

The gene report must come first. Imatinib is of no use against a PDGFRA D842V change, and giving it only delays the right treatment.

How long are tablets given before the operation?

Usually six to nine months, until two scans a few weeks apart show no further change. The aim is to operate at that plateau, not at the first shrinkage.

  1. Biopsy and gene report first. They fix the tablet and the dose.
  2. A scan after the first two to three months, to check that the tumour is responding. A tumour often turns less dense on CT before it gets smaller.
  3. Scans repeated every two to three months until the response stops changing.
  4. The operation at that point, with the tablets held for a short time just before, as your team advises.
  5. Tablets restarted soon after, once you are eating.

Going on past the plateau does not shrink the tumour further. It gives the tumour time to learn a new trick, a second gene change that makes the tablet fail. So the operation is not put off for a longer wait.

Who needs tablets after the operation?

Only patients whose tumour is likely to return and whose gene type responds to imatinib. Three years is usual, and a few at the highest risk may be offered longer.

  • A low-risk tumour needs only follow-up scans. The tablets would add side effects for little gain.
  • An intermediate-risk tumour is discussed case by case, as gene type and site count here.
  • A high-risk tumour with a KIT change is treated for three years. Those with a KIT exon 9 change may need a higher dose.
  • A PDGFRA D842V or SDH-deficient tumour gains little from imatinib, so it is not given after the operation.

Returns are most likely in the months after the tablets stop. That is why the length is fixed with care, and why scans stay closer together at that time.

What if the GIST has already spread?

Then imatinib starts the plan and goes on for as long as it controls the disease. Stopping it, even when the scan looks clear, usually lets the tumour grow again.

  • The tablets are started once the biopsy and gene report are in, at the dose that suits the gene type.
  • Scans every two to three months in the first year show whether it is working.
  • An operation is kept for chosen patients. Their disease has responded and stayed steady for months, and nearly all of it can be removed.
  • One lump may grow while the rest stays quiet. It is treated on its own, by operation, heat or radiation, and the same tablet carries on.

Removing a tumour while it is actively growing on the tablet does not help. It is better to change the medicine in that case.

What comes next if imatinib stops working?

The next medicines follow in a set order: a higher imatinib dose where it applies, then sunitinib, regorafenib and ripretinib. Each was tested after the one before it failed.

  • Before calling it failure, we check that tablets were taken every day and that the scan really shows growth.
  • A fresh biopsy may be taken, because a new gene change decides which medicine will work.
  • Avapritinib is for the PDGFRA D842V change and is not a general next step.
  • When the usual medicines are used up, a clinical trial at a reference centre is an option.

Skipping the order loses benefit. A later medicine given too early cannot be given again with the same value.

Who plans this with you?

A team does, because each step touches the next. A surgeon, a cancer physician, a radiologist and a pathologist look at your reports together before any step is taken.

  • The surgeon judges whether and when an operation is safe and complete.
  • The cancer physician sets the tablet, the dose and the length of treatment.
  • The radiologist reads whether the tumour is responding, which a size count alone can miss.
  • The pathologist reports the gene change and the risk group.

The team meets again at each turn. These are before tablets start, before the operation, after it and when the tablets are due to stop. The evidence behind these steps is set out in our post on the key GIST studies.

Frequently asked questions

Is surgery always the first step in GIST?

No. A tumour that can be removed whole and safely is operated on first. A large one, or one that would need a bigger operation, often gets imatinib first to shrink it.

Can a tumour that is too big to remove now be removed later?

Often yes. Imatinib for several months can shrink it so that it comes out cleanly. Sometimes the operation is smaller than it would have been at the start.

Do I still need the operation if the tablets have shrunk the tumour?

Usually yes. Tablets seldom clear a GIST completely, and the part that is left can grow again. The operation removes it, and the tablets are restarted afterwards.

Do I stop imatinib before the operation?

Only for a short time, as your team advises, and it is started again soon after you are eating. Do not stop or change the dose on your own.

Why is imatinib not used if my report says PDGFRA D842V?

This gene change does not respond to imatinib. Giving it would only delay the right treatment. Surgery is used if the tumour is removable, and a different medicine, avapritinib, if medicine is needed.

Can surgery be done if the GIST has spread?

Sometimes. It is kept for patients whose disease has responded to tablets and stayed steady for months. Nearly all of it must be removable. For most, tablets are the main treatment.

Why can I not stop imatinib after a complete operation if my risk is high?

Studies show that returns mostly follow stopping. The tablets hold the tumour back while they are taken. So the length of treatment is set with care by your risk group.

Related pages

For the full picture of GIST and its treatment, start at the GIST treatment in Ahmedabad page. For questions before you travel, call +91-63555-64601.

Where Dr Harsh Shah sees patients and operates

Dr Harsh Shah — Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad
Dr. Jivraj Mehta Hospital, Dr Jivraj Mehta Marg, Vasna, Ahmedabad 380007.
Consultations, review of reports and scans, operations and follow-up. OPD Monday to Saturday, 9 am to 5 pm.
Appointments: +91-63555-64601 · +91-63590-11009 · Hospital 079-2663 6363
Directions to the hospital · WhatsApp +91-63555-64601

Told you have a GIST and unsure whether the operation or the tablets come first? The order is not the same for everyone. It depends on where the tumour sits, how big it is, whether it has spread and what your gene report shows. Dr Harsh Shah, a stomach cancer surgeon in Ahmedabad, will set the order from your own reports. Bring your scans, biopsy report and gene report. You can call us or book by message. Call For Appointment Book on WhatsApp Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Get health updates from Dr Harsh Shah on WhatsApp

Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.

Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.

Dr. Harsh J Shah
Dr Harsh Shah, Gastro, Cancer & Laparoscopic Surgeon, Ahmedabad
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.